Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Pfizer to begin shipping Inflectra next month

Oct. 18, 2016

DNAJB6 mutation is associated with myofibrillar myopathies

Oct. 17, 2016

Novel BICD2 mutations may cause SMALED2

Oct. 17, 2016

Akros initiates phase II trial of JTE-051 in active rheumatoid arthritis

Oct. 17, 2016

Novel SPEG gene mutation linked to centronuclear myopathy

Oct. 13, 2016

Meiji Seika opens phase I pharmacokinetic bioequivalence study of DMB-3113 and adalimumab in Japan

Oct. 11, 2016

Gilead initiates phase II trial of GS-9876 in patients with active rheumatoid arthritis

Oct. 6, 2016

GlaxoSmithKline presents bromodomain inhibitors

Oct. 5, 2016

TAK1 is a promising new target for osteoarthritis

Oct. 5, 2016

Coherus Biosciences regains rights for CHS-0214 from Shire

Sep. 28, 2016

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.